Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 544

    Four Pfizer brands to be acquired by Piramal Enterprises for Rs 110 cr

    Four Pfizer brands to be acquired by Piramal Enterprises for Rs 110 cr

    savita thakur thakur15 May 2016 4:12 PM IST
    New Delhi : Ajay Piramal-led Piramal Enterprises has entered into an agreement to acquire four brands from Pfizer for a consideration of Rs 110...
    Sun Pharma denies being aware of adverse findings in Ranbaxy plants

    Sun Pharma denies being aware of adverse findings in Ranbaxy plants

    Geeta Sharma Sharma15 May 2016 4:11 PM IST
    Sun pharmaceuticals, the new owners of Ranbaxy have denied knowledge of any adverse findings related to their new Ranbaxy plant acquisition. The...
    Regeneron CEO calls ICER critique of new cholesterol therapy non scientific

    Regeneron CEO calls ICER critique of new cholesterol therapy non scientific

    savita thakur thakur15 May 2016 9:11 AM IST
    New York : Regeneron Pharmaceuticals Chief Executive Leonard Schleifer on Thursday took aim at an influential drug pricing watchdog, saying a critique...
    USFDA nod to Aurobindo Pharmas generic Zolmitriptantab for migraine

    USFDA nod to Aurobindo Pharma's generic Zolmitriptantab for migraine

    savita thakur thakur14 May 2016 2:39 PM IST
    New Delhi : Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine,...
    Pfizer Inc blocks its drug use in lethal injections

    Pfizer Inc blocks its drug use in lethal injections

    savita thakur thakur14 May 2016 2:38 PM IST
    New York : Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest US drugmaker said on Friday."We...
    Dr Bakshi, Chairman Baksons Drugs Acquitted in Corruption Case

    Dr Bakshi, Chairman Bakson's Drugs Acquitted in Corruption Case

    savita thakur thakur13 May 2016 2:19 PM IST
    New Delhi : Chairman of Bakson's drugs and pharmaceuticals, Dr SPS Bakshi, along with five other doctors has been acquitted by a special court in a...
    AstraZeneca Drug Wins Orphan Status in Thyroid Cancer

    AstraZeneca Drug Wins Orphan Status in Thyroid Cancer

    savita thakur thakur13 May 2016 2:16 PM IST
    London : An experimental AstraZeneca drug that failed last year as a treatment for a rare cancer of the eye has been awarded special "orphan" status...
    Morepen Laboratories Scores No. 1 Position Globally for its Bulk Drug Montelukast

    Morepen Laboratories Scores No. 1 Position Globally for its Bulk Drug Montelukast

    savita thakur thakur13 May 2016 2:15 PM IST
    New Delhi : Morepen Laboratories Ltd. has established a leadership position for its anti-asthmatic bulk drug Montelukast in the global market. As per...
    Sanofi Recalls Batches of Painkiller Combiflam in India

    Sanofi Recalls Batches of Painkiller Combiflam in India

    savita thakur thakur13 May 2016 2:09 PM IST
    Mumbai : Sanofi is recalling some batches of its painkiller Combiflam in India after the country's drugs regulator found the lots were substandard,...
    Gilead’s $1000 Hepatitis C pill Sovaldi (Sofosbuvir) gets a patent in India

    Gilead’s $1000 Hepatitis C pill Sovaldi (Sofosbuvir) gets a patent in India

    Geeta Sharma Sharma12 May 2016 1:09 PM IST
    Gilead’s $1000 Hepatitis C pill Sovaldi (Sofosbuvir) has received a patent in India.The Indian patent Office granted Gilead this patent on Monday....
    Zydus Cadila gets USFDA nod for generic diabetes drug Glyburide

    Zydus Cadila gets USFDA nod for generic diabetes drug Glyburide

    savita thakur thakur12 May 2016 1:07 PM IST
    New Delhi : Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diabetic Glyburide tablets in the...
    Doctors still looking for the Correct FDCs for TB medication for children in India

    Doctors still looking for the Correct FDCs for TB medication for children in India

    savita thakur thakur11 May 2016 4:25 PM IST
    New Delhi: Treatment of Tuberculosis among children in India seems to be falling short on strength of dose administered to child patients, according...
    PrevNext

    Popular Stories

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Unjustified medication shortened 456 lives in a UK hospital, report says

    Unjustified medication shortened 456 lives in a UK hospital, report says

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok